Pfizer R&D Facility Expansion
This integrated delivery project resonates a connection with science through the purposeful renovation of two buildings on Pfizer’s 4.5-acre site with advanced facilities, including specialized laboratories and equipment. A site focused on the discovery, development, and commercialization of small molecule cancer treatment. This multi-phased renovation enhances science and the workplace experience while improving safety, efficiency, and functionality.
LJC’s national team helped refine Pfizer’s global workplace design standards to respond to site-specific requirements and COVID-19 protocols. Collaborating closely with Pfizer’s leadership, detailed phasing of the project minimized disruption while protecting the lab environments.
Renovations to this campus include lab improvements for Enzymology & Structural Biology, Cell Biology, and new labs for Medical Chemistry along with ancillary support including glass wash, freezer rooms, and robotics. Upgrades include neighborhood workstations with collaboration spaces, meditation room, hackable creative space, and new MEPFP systems.
Documentation of the existing building were not available. The team performed extensive on-site building assessments to determine the status of all building systems using laser scanning. 3D scans allowed the team to integrate the architectural & MEP improvements and minimize surprises during construction.
Renovations are scheduled for completion in 2022.